Published in J Cell Biochem on September 14, 2000
Lactoferrin as a natural immune modulator. Curr Pharm Des (2009) 1.40
In vivo effects of bifidobacteria and lactoferrin on gut endotoxin concentration and mucosal immunity in Balb/c mice. Dig Dis Sci (2004) 1.13
Lactoferrin modulation of IL-12 and IL-10 response from activated murine leukocytes. Med Microbiol Immunol (2007) 0.91
Immunomodulatory effects of lactoferrin. Acta Pharmacol Sin (2014) 0.90
Influence of bovine lactoferrin on expression of presentation molecules on BCG-infected bone marrow derived macrophages. Biochimie (2008) 0.90
Lactoferrin modulation of BCG-infected dendritic cell functions. Int Immunol (2009) 0.86
Lactoferrin modulation of antigen-presenting-cell response to BCG infection. Postepy Hig Med Dosw (Online) (2007) 0.84
Usefulness of fecal lactoferrin in predicting and monitoring the clinical severity of infectious diarrhea. World J Gastroenterol (2011) 0.83
A complex of lactoferrin with monophosphoryl lipid A is an efficient adjuvant of the humoral and cellular immune response in mice. Med Microbiol Immunol (2006) 0.83
Comparing efficacy of BCG/lactoferrin primary vaccination versus booster regimen. Tuberculosis (Edinb) (2011) 0.81
Lactoferrin Augmentation of the BCG Vaccine Leads to Increased Pulmonary Integrity. Tuberc Res Treat (2011) 0.81
IKVAV regulates ERK1/2 and Akt signalling pathways in BMMSC population growth and proliferation. Cell Prolif (2014) 0.79
Synthesis of heparan sulfate with cyclophilin B-binding properties is determined by cell type-specific expression of sulfotransferases. J Biol Chem (2009) 0.79
Lactoferrin from Milk: Nutraceutical and Pharmacological Properties. Pharmaceuticals (Basel) (2016) 0.78
Lactoferrin targets T cells in the small intestine. J Gastroenterol (2010) 0.78
Structural characterization of the interaction of human lactoferrin with calmodulin. PLoS One (2012) 0.77
Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells. Proc Natl Acad Sci U S A (1997) 5.24
Isolation and characterization of sex-linked female-sterile mutants in Drosophila melanogaster. Genetics (1975) 3.91
Genetic Analysis of Three Dominant Female-Sterile Mutations Located on the X Chromosome of DROSOPHILA MELANOGASTER. Genetics (1983) 3.36
Human lactotransferrin: amino acid sequence and structural comparisons with other transferrins. Eur J Biochem (1984) 2.82
A clonal analysis of the roles of somatic cells and germ line during oogenesis in Drosophila. Dev Biol (1981) 2.78
Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases. Nat Cell Biol (1999) 2.78
Randomized comparison of reduction and fixation, bipolar hemiarthroplasty, and total hip arthroplasty. Treatment of displaced intracapsular hip fractures in healthy older patients. J Bone Joint Surg Am (2006) 2.71
Flamenco, a gene controlling the gypsy retrovirus of Drosophila melanogaster. Genetics (1995) 2.41
Specificity of twelve lectins towards oligosaccharides and glycopeptides related to N-glycosylproteins. Eur J Biochem (1981) 2.30
Isolation and Characterization of Sex-Linked Female-Sterile Mutants in DROSOPHILA MELANOGASTER with Special Attention to Eggshell Mutants. Genetics (1983) 2.23
Comparative study of the iron-binding properties of human transferrins. I. Complete and sequential iron saturation and desaturation of the lactotransferrin. Biochim Biophys Acta (1980) 1.97
Studies on glycoconjugates. LXIV. Complete structure of two carbohydrate units of human serotransferrin. FEBS Lett (1975) 1.92
Intracellular targets of cyclin-dependent kinase inhibitors: identification by affinity chromatography using immobilised inhibitors. Chem Biol (2000) 1.75
Cellular and molecular mechanisms of senescent erythrocyte phagocytosis by macrophages. A review. Biochimie (1998) 1.62
Carbohydrate deficient glycoprotein syndrome type II: a deficiency in Golgi localised N-acetyl-glucosaminyltransferase II. Arch Dis Child (1994) 1.60
Lactoferrin: a modulator of immune and inflammatory responses. Cell Mol Life Sci (2005) 1.59
Lactoferrin: a multifunctional glycoprotein involved in the modulation of the inflammatory process. Clin Chem Lab Med (1999) 1.55
Primary structure of the glycans from human lactotransferrin. Eur J Biochem (1982) 1.53
The role of dosage of the region 7D1-7D5-6 of the X chromosome in the production of homeotic transformations in Drosophila melanogaster. Genetics (1980) 1.50
Lactoferrin-lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide. Biochem J (1995) 1.41
Structure and function of poly(ADP-ribose) polymerase. Mol Cell Biochem (1994) 1.38
Displaced intracapsular hip fractures in fit, older people: a randomised comparison of reduction and fixation, bipolar hemiarthroplasty and total hip arthroplasty. Health Technol Assess (2005) 1.35
Bacteriostasis of a milk-sensitive strain of Escherichia coli by immunoglobulins and iron-binding proteins in association. Immunology (1978) 1.32
Molecular cloning of a lipolysis-stimulated remnant receptor expressed in the liver. J Biol Chem (1999) 1.26
Lactoferrin inhibits the endotoxin interaction with CD14 by competition with the lipopolysaccharide-binding protein. Infect Immun (1998) 1.25
Cyclodextrins in topical drug formulations: theory and practice. Int J Pharm (2001) 1.24
Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase. Biochem J (1997) 1.22
Cytosolic location of an endo-N-acetyl-beta-D-glucosaminidase activity in rat liver and kidney. Biochem J (1979) 1.22
Cranial pachymeningitis of unknown origin: a study of seven cases. Neurology (1993) 1.19
Iron binding proteins and influx of iron across the duodenal brush border. Evidence for specific lactotransferrin receptors in the human intestine. Biochim Biophys Acta (1979) 1.18
Kinetic studies of aminoglycoside acetyltransferase and phosphotransferase from Staphylococcus aureus RPAL. Relationship between the two activities. Eur J Biochem (1983) 1.16
Comparative circular dichroism studies of iron-free and iron-saturated forms of human serotransferrin and lactortransferrin. FEBS Lett (1976) 1.16
[Comparative studies of the structure of human transferrin and lactotransferrin. "Fingerprinting" of the protease hydrolysates of both glycoproteins]. C R Seances Soc Biol Fil (1966) 1.15
Expression of human lactotransferrin receptors in phytohemagglutinin-stimulated human peripheral blood lymphocytes. Isolation of the receptors by antiligand-affinity chromatography. Eur J Biochem (1989) 1.15
Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier. J Biol Chem (1999) 1.15
Molecular cloning and sequence analysis of bovine lactotransferrin. Eur J Biochem (1991) 1.13
Spontaneous development of drug resistance: mismatch repair and p53 defects in resistance to cisplatin in human tumor cells. Oncogene (2000) 1.10
Human lactoferrin interacts with soluble CD14 and inhibits expression of endothelial adhesion molecules, E-selectin and ICAM-1, induced by the CD14-lipopolysaccharide complex. Infect Immun (2000) 1.08
Crystalline L-ribulose 5-phosphate 4-epimerase from Escherichia coli. J Biol Chem (1968) 1.08
Structure of nine sialyl-oligosaccharides accumulated in urine of eleven patients with three different types of sialidosis. Mucolipidosis II and two new types of mucolipidosis. Eur J Biochem (1977) 1.08
Are some aminoglycoside antibiotics inactivating enzymes polyfunctional? Ann Microbiol (Paris) (1978) 1.08
[Comparative study of the sugar and amino acid compositions of human transferrin and lacto-transferrin]. Experientia (1965) 1.07
Primary structure of glycans isolated from human leucocyte lactotransferrin. Absence of fucose residues questions the proposed mechanism of hyposideraemia. Biochem J (1990) 1.06
Selective assay for CyPA and CyPB in human blood using highly specific anti-peptide antibodies. J Immunol Methods (1995) 1.06
Characterization and localization of an iron-binding 18-kDa glycopeptide isolated from the N-terminal half of human lactotransferrin. Biochim Biophys Acta (1984) 1.06
Demonstration and partial characterization of endo-N-acetyl-beta-D-glucosaminidase in human tissues. FEBS Lett (1981) 1.05
Iron acquisition by Helicobacter pylori: importance of human lactoferrin. Infect Immun (1993) 1.05
Structures of a legume lectin complexed with the human lactotransferrin N2 fragment, and with an isolated biantennary glycopeptide: role of the fucose moiety. Structure (1994) 1.05
Recognition of Lewis x derivatives present on mucins by flagellar components of Pseudomonas aeruginosa. Infect Immun (2001) 1.04
The complete amino acid sequence of bovine milk angiogenin. FEBS Lett (1988) 1.03
Demonstration and cytosolic location of an endo-N-acetyl-beta-D-glucosaminidase activity towards an asialo-N-acetyl-lactosaminic-type substrate in rat liver. Biochem J (1980) 1.02
Pseudomonas aeruginosa binds to neoglycoconjugates bearing mucin carbohydrate determinants and predominantly to sialyl-Lewis x conjugates. Glycobiology (1999) 1.01
The N-terminal domain I of human lactotransferrin binds specifically to phytohemagglutinin-stimulated peripheral blood human lymphocyte receptors. FEBS Lett (1989) 1.01
The lysine pathway as a target for a new genera of synthetic antibacterial antibiotics? J Med Chem (1986) 1.01
Molecular interactions between human lactotransferrin and the phytohemagglutinin-activated human lymphocyte lactotransferrin receptor lie in two loop-containing regions of the N-terminal domain I of human lactotransferrin. Biochemistry (1992) 1.00
Lactotransferrin binding to its platelet receptor inhibits platelet aggregation. Eur J Biochem (1993) 0.99
The antenatal use of betamethasone in the prevention of respiratory distress syndrome: a controlled double-blind study. Pediatrics (1979) 0.99
Heterogeneity of bovine lactotransferrin glycans. Characterization of alpha-D-Galp-(1-->3)-beta-D-Gal- and alpha-NeuAc-(2-->6)-beta-D-GalpNAc-(1-->4)- beta-D-GlcNAc-substituted N-linked glycans. Carbohydr Res (1992) 0.99
Human osteosarcoma cells express functional receptor activator of nuclear factor-kappa B. J Pathol (2007) 0.98
Two distinct regions of cyclophilin B are involved in the recognition of a functional receptor and of glycosaminoglycans on T lymphocytes. J Biol Chem (1999) 0.98
[Paroxysmal motor manifestations in multiple sclerosis]. Presse Med (1970) 0.98
[Bromelain in blunt injuries of the locomotor system. A study of observed applications in general practice]. Fortschr Med (1995) 0.98
Presence of fucosylated triantennary, tetraantennary and pentaantennary glycans in transferrin synthesized by the human hepatocarcinoma cell line Hep G2. Eur J Biochem (1989) 0.98
Porins OmpC and PhoE of Escherichia coli as specific cell-surface targets of human lactoferrin. Binding characteristics and biological effects. J Biol Chem (1999) 0.98
[Complete structure of glycopeptides isolated from IgG immunoglobulins of cow colostrum]. Biochimie (1976) 0.97
Characterization and properties of the human and bovine lactotransferrins extracted from the faeces of newborn infants. Acta Paediatr Scand (1982) 0.97
Human lactoferrin induces phenotypic and functional changes in murine splenic B cells. Immunology (1995) 0.97
Transient hemiballism/hemichorea due to an ipsilateral subthalamic nucleus infarction. Neurology (1996) 0.96
Involvement of two classes of binding sites in the interactions of cyclophilin B with peripheral blood T-lymphocytes. Biochem J (1998) 0.96
[Chromatographic fractionation and studies on microheterogenity of cow lactotransferrin prepared by an original procedure]. C R Acad Sci Hebd Seances Acad Sci D (1977) 0.96
Alterations in the fatty acid composition of rat brain cells (neurons, astrocytes, and oligodendrocytes) and of subcellular fractions (myelin and synaptosomes) induced by a diet devoid of n-3 fatty acids. J Neurochem (1984) 0.96
Chemical and enzymic degradations of nucleoside mono- and diphosphate sugars. I. Determination of the degradation rate during the glycosyltransferase assays. Biochim Biophys Acta (1979) 0.96
Characterization of surface binding sites for cyclophilin B on a human tumor T-cell line. J Biol Chem (1994) 0.95
Lactotransferrin receptor of mouse small-intestinal brush border. Binding characteristics of membrane-bound and triton X-100-solubilized forms. Biochem J (1988) 0.94
[Description of a new type of melituria, called sialuria]. Clin Chim Acta (1968) 0.94
Reduction of operating and recovery room times and overnight hospital stays with interscalene blocks as sole anesthetic technique for rotator cuff surgery. Minerva Anestesiol (2001) 0.93
The N-terminal Arg2, Arg3 and Arg4 of human lactoferrin interact with sulphated molecules but not with the receptor present on Jurkat human lymphoblastic T-cells. Biochem J (1997) 0.93
A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells. Oncogene (2008) 0.93
[Glycoproteins. 38. Demonstration of the N-(beta-aspartyl)-N-acetylglucosaminylamine nature of the glyco-protein bond in human transferrin]. Bull Soc Chim Biol (Paris) (1969) 0.93
[Anterior choroidal artery syndrome. Neuropsychological study of 4 cases]. Rev Neurol (Paris) (1983) 0.92
Molecular mechanisms of erythrophagocytosis: flow cytometric quantitation of in vitro erythrocyte phagocytosis by macrophages. Cytometry (1997) 0.92
[Cerebral infarct and pure sensory deficit]. Rev Neurol (Paris) (1989) 0.92
Intranasal administration of midazolam in a cyclodextrin based formulation: bioavailability and clinical evaluation in humans. Pharmazie (2001) 0.92
Primary structure of two sialylated triantennary glycans from human serotransferrin. FEBS Lett (1985) 0.92
Structure determination of two oligomannoside-type glycopeptides obtained from bovine lactotransferrin, by 500 MHz 1H-NMR spectroscopy. Biochim Biophys Acta (1981) 0.92
Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells. J Cell Biochem (1999) 0.91